Concourse Financial Group Securities, Inc. Harvard Bioscience Inc Transaction History
Concourse Financial Group Securities, Inc.
- $1.64 Billion
- Q3 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding HBIO
# of Institutions
107Shares Held
32.3MCall Options Held
1.2KPut Options Held
1.2K-
Black Rock Inc. New York, NY2.84MShares$7.31 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.77MShares$7.12 Million0.49% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.56MShares$6.57 Million0.9% of portfolio
-
Amh Equity LTD2.39MShares$6.14 Million8.88% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.12MShares$5.44 Million0.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $107M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...